Lintuzumab-Ac225

lintuzumab-actinium-225

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Lintuzumab-Ac225, covering 2023-07-20 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: Lintuzumab-Ac225 in Combination with Cladribine + Cytarabine + Filgastrim + Mitoxantrone (CLAG-M) for Relapsed/Refractory Acute Myeloid Leukemia [Phase 1]

See pricing